세계의 의료 영양 시장 - 규모, 점유율, 성장 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2024-2032년)

Growth Factors of medical nutrition Market

The global medical nutrition market continues to expand steadily as chronic diseases rise, awareness of clinical nutrition grows, and healthcare systems worldwide increasingly recognize the importance of nutrition therapy in both acute and long-term care. According to the report, the market size reached USD 51.26 billion in 2024, driven by an aging global population and increasing demand for medical nutrition therapy (MNT). The market is projected to grow further to USD 52.94 billion in 2025 and eventually reach USD 85.05 billion by 2032, reflecting a 7.0% CAGR during the forecast period. North America dominated the global market in 2024, accounting for 34.96% of total revenue due to its strong healthcare infrastructure, high prevalence of chronic diseases, and growing partnerships to advance clinical nutrition solutions.

Key Market Insights

Medical Nutrition Therapy (MNT) involves tailored nutrition interventions used to manage conditions such as diabetes, gastrointestinal disorders, cardiovascular diseases, chronic respiratory illness, and kidney disease. This treatment utilizes nutrition education and behavioral counseling delivered by clinical dietitians as part of multidisciplinary medical care. In recent years, demand has surged due to growing global awareness about the importance of nutrition in preventing and managing chronic conditions.

The market is semi-consolidated with major players such as Abbott, Nestle, Nutricia (Danone), B. Braun SE, Fresenius Kabi AG, and Reckitt Benckiser Group PLC. These companies continue to expand portfolios and secure regulatory approvals to introduce disease-specific and patient-focused nutritional products. For example, in April 2023, Nutricia launched a memory supplement in the U.S. to support synapse strengthening.

Market Dynamics

Drivers: Rising Burden of Chronic Diseases

The increasing prevalence of chronic illnesses significantly boosts market demand. Conditions such as cancer, Parkinson's disease, and neurological disorders often impair normal nutrient intake. According to the American Parkinson Disease Association, 1.3 million people in North America will be living with Parkinson's disease by 2030. Similarly, aging populations contribute heavily to chronic conditions requiring clinical nutrition. In the U.S., 17.3% of the population was aged 65+ in 2022, a number projected to reach 22.0% by 2040.

Growing awareness of home-based medical nutrition also fuels demand, as elderly patients increasingly prefer clinical nutrition services at home for convenience, improved mobility, and enhanced quality of life.

Restraints: Limited Reimbursement Policies

Coverage for medical foods and nutrition therapies varies widely across regions. While countries in Europe such as France, Germany, Spain, and the Netherlands offer substantial reimbursement, the U.S. provides limited coverage outside hospital settings. This restricts access for lower-income patients. Additionally, lack of financial incentives for research in clinical nutrition technologies can deter innovation.

Opportunities: AI-Powered Personalized Nutrition

Rising demand for disease-specific and personalized nutrition products creates significant opportunities for manufacturers. Companies such as Abbott are increasing R&D investments-USD 2,741.0 million in 2023-into AI-enhanced nutrition solutions for gastrointestinal disorders, immune health, and metabolic conditions. Advances in AI are enabling accurate nutrition delivery and real-time monitoring for critically ill patients.

Market Trends

A major trend in the market is the shift toward disease-specific formulations, such as those for oncology, renal disorders, and metabolic diseases. Companies are launching specialized formulas to improve treatment outcomes. For instance, Abbott introduced its Similac PM 60/40 metabolic formula to support infants with specific renal conditions.

Personalized nutrition is also gaining traction, particularly in Japan, where 53% of consumers express interest in tailored nutritional solutions. Additionally, global focus on preventive healthcare is rising, positioning clinical nutrition as an essential tool for disease prevention.

Regional Outlook

North America

North America led the global market with a value of USD 17.92 billion in 2024, supported by strong R&D, product launches, and collaborations. Companies frequently introduce new solutions at major U.S. medical conferences. Baxter's ExactaMix Pro launch in 2022 is an example of growing innovation in the region.

Europe

Europe held the second-largest share in 2024, driven by favorable reimbursement policies and strong research collaborations like the Fresenius Kabi-ESICM partnership supporting clinical nutrition education and critical care nutrition.

Asia Pacific

Asia Pacific is expected to grow moderately from 2025 to 2032, fueled by an expanding elderly population and rising awareness of disease-specific nutrition. Economic development and increased healthcare spending are supporting market expansion in China, India, and Japan.

Latin America and Middle East & Africa

These regions are witnessing steady growth due to improving healthcare access, rising chronic diseases, and increased awareness of nutrition therapy.

Conclusion

Driven by rising chronic diseases, aging populations, and increased focus on personalized care, the medical nutrition market will grow from USD 51.26 billion in 2024 to USD 85.05 billion by 2032. Continued innovation, AI-integrated nutrition solutions, and strategic collaborations will shape the future of clinical nutrition worldwide.

Growth rate CAGR of 7.0% from 2025-2032

Segmentation

By Type

• Service
  • Nutrition Assessment
  • Meal Preparation & Delivery
  • Feeding Assistance
  • Others
• Product
  • Enteral Nutrition
  • Parenteral Nutrition
• Partial Parenteral Nutrition (PPN)
• Total Parenteral Nutrition (TPN)

By Age Group

• Adults
• Pediatrics

By Route of Administration

• Oral
• Nasal
• Parenteral
• Others

By Form

• Powder
• Liquid

By Therapeutic Area

• Oncology
• Neurological Disorders
• Gastrointestinal Disorders
• Diabetes
• Kidney Disorders
• Cardiovascular Disorders
• Others

By End-user

• Hospitals & ASCs
• Specialty Clinics
• Homecare Settings
• Others

By Region

• North America (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
  • U.S.
  • Canada
• Europe ( By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of the Asia Pacific
• Latin America (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
  • GCC
  • South Africa
• Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Chronic Diseases, by Key Countries/Sub-regions, 2023/2024
• 4.2. New Product Launches, by Key Players
• 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Service
    • 5.1.1.1. Nutrition Assessment
    • 5.1.1.2. Meal Preparation & Delivery
    • 5.1.1.3. Feeding Assistance
    • 5.1.1.4. Others
  • 5.1.2. Product
    • 5.1.2.1. Enteral Nutrition
    • 5.1.2.2. Parenteral Nutrition
      • 5.1.2.2.1. Partial Parenteral Nutrition (PPN)
      • 5.1.2.2.2. Total Parenteral Nutrition (TPN)
• 5.2. Market Analysis, Insights and Forecast - By Age Group
  • 5.2.1. Adults
  • 5.2.2. Pediatrics
• 5.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 5.3.1. Oral
  • 5.3.2. Nasal
  • 5.3.3. Parenteral
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By Form
  • 5.4.1. Powder
  • 5.4.2. Liquid
• 5.5. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 5.5.1. Oncology
  • 5.5.2. Neurological Disorders
  • 5.5.3. Gastrointestinal Disorders
  • 5.5.4. Diabetes
  • 5.5.5. Kidney Disorders
  • 5.5.6. Cardiovascular Disorders
  • 5.5.7. Others
• 5.6. Market Analysis, Insights and Forecast - By End-user
  • 5.6.1. Hospitals & ASCs
  • 5.6.2. Specialty Clinics
  • 5.6.3. Homecare Settings
  • 5.6.4. Others
• 5.7. Market Analysis, Insights and Forecast - By Region
  • 5.7.1. North America
  • 5.7.2. Europe
  • 5.7.3. Asia Pacific
  • 5.7.4. Latin America
  • 5.7.5. Middle East & Africa

6. North America Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Service
    • 6.1.1.1. Nutrition Assessment
    • 6.1.1.2. Meal Preparation & Delivery
    • 6.1.1.3. Feeding Assistance
    • 6.1.1.4. Others
  • 6.1.2. Product
    • 6.1.2.1. Enteral Nutrition
    • 6.1.2.2. Parenteral Nutrition
      • 6.1.2.2.1. Partial Parenteral Nutrition (PPN)
      • 6.1.2.2.2. Total Parenteral Nutrition (TPN)
• 6.2. Market Analysis, Insights and Forecast - By Age Group
  • 6.2.1. Adults
  • 6.2.2. Pediatrics
• 6.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 6.3.1. Oral
  • 6.3.2. Nasal
  • 6.3.3. Parenteral
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By Form
  • 6.4.1. Powder
  • 6.4.2. Liquid
• 6.5. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 6.5.1. Oncology
  • 6.5.2. Neurological Disorders
  • 6.5.3. Gastrointestinal Disorders
  • 6.5.4. Diabetes
  • 6.5.5. Kidney Disorders
  • 6.5.6. Cardiovascular Disorders
  • 6.5.7. Others
• 6.6. Market Analysis, Insights and Forecast - By End-user
  • 6.6.1. Hospitals & ASCs
  • 6.6.2. Specialty Clinics
  • 6.6.3. Homecare Settings
  • 6.6.4. Others
• 6.7. Market Analysis, Insights and Forecast - By Country
  • 6.7.1. U.S.
  • 6.7.2. Canada

7. Europe Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Service
    • 7.1.1.1. Nutrition Assessment
    • 7.1.1.2. Meal Preparation & Delivery
    • 7.1.1.3. Feeding Assistance
    • 7.1.1.4. Others
  • 7.1.2. Product
    • 7.1.2.1. Enteral Nutrition
    • 7.1.2.2. Parenteral Nutrition
      • 7.1.2.2.1. Partial Parenteral Nutrition (PPN)
      • 7.1.2.2.2. Total Parenteral Nutrition (TPN)
• 7.2. Market Analysis, Insights and Forecast - By Age Group
  • 7.2.1. Adults
  • 7.2.2. Pediatrics
• 7.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 7.3.1. Oral
  • 7.3.2. Nasal
  • 7.3.3. Parenteral
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By Form
  • 7.4.1. Powder
  • 7.4.2. Liquid
• 7.5. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 7.5.1. Oncology
  • 7.5.2. Neurological Disorders
  • 7.5.3. Gastrointestinal Disorders
  • 7.5.4. Diabetes
  • 7.5.5. Kidney Disorders
  • 7.5.6. Cardiovascular Disorders
  • 7.5.7. Others
• 7.6. Market Analysis, Insights and Forecast - By End-user
  • 7.6.1. Hospitals & ASCs
  • 7.6.2. Specialty Clinics
  • 7.6.3. Homecare Settings
  • 7.6.4. Others
• 7.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.7.1. Germany
  • 7.7.2. U.K.
  • 7.7.3. France
  • 7.7.4. Italy
  • 7.7.5. Spain
  • 7.7.6. Scandinavia
  • 7.7.7. Rest of Europe

8. Asia Pacific Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Service
    • 8.1.1.1. Nutrition Assessment
    • 8.1.1.2. Meal Preparation & Delivery
    • 8.1.1.3. Feeding Assistance
    • 8.1.1.4. Others
  • 8.1.2. Product
    • 8.1.2.1. Enteral Nutrition
    • 8.1.2.2. Parenteral Nutrition
      • 8.1.2.2.1. Partial Parenteral Nutrition (PPN)
      • 8.1.2.2.2. Total Parenteral Nutrition (TPN)
• 8.2. Market Analysis, Insights and Forecast - By Age Group
  • 8.2.1. Adults
  • 8.2.2. Pediatrics
• 8.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 8.3.1. Oral
  • 8.3.2. Nasal
  • 8.3.3. Parenteral
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By Form
  • 8.4.1. Powder
  • 8.4.2. Liquid
• 8.5. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 8.5.1. Oncology
  • 8.5.2. Neurological Disorders
  • 8.5.3. Gastrointestinal Disorders
  • 8.5.4. Diabetes
  • 8.5.5. Kidney Disorders
  • 8.5.6. Cardiovascular Disorders
  • 8.5.7. Others
• 8.6. Market Analysis, Insights and Forecast - By End-user
  • 8.6.1. Hospitals & ASCs
  • 8.6.2. Specialty Clinics
  • 8.6.3. Homecare Settings
  • 8.6.4. Others
• 8.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.7.1. China
  • 8.7.2. India
  • 8.7.3. Japan
  • 8.7.4. Australia
  • 8.7.5. Southeast Asia
  • 8.7.6. Rest of Asia Pacific

9. Latin America Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Service
    • 9.1.1.1. Nutrition Assessment
    • 9.1.1.2. Meal Preparation & Delivery
    • 9.1.1.3. Feeding Assistance
    • 9.1.1.4. Others
  • 9.1.2. Product
    • 9.1.2.1. Enteral Nutrition
    • 9.1.2.2. Parenteral Nutrition
      • 9.1.2.2.1. Partial Parenteral Nutrition (PPN)
      • 9.1.2.2.2. Total Parenteral Nutrition (TPN)
• 9.2. Market Analysis, Insights and Forecast - By Age Group
  • 9.2.1. Adults
  • 9.2.2. Pediatrics
• 9.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 9.3.1. Oral
  • 9.3.2. Nasal
  • 9.3.3. Parenteral
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By Form
  • 9.4.1. Powder
  • 9.4.2. Liquid
• 9.5. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 9.5.1. Oncology
  • 9.5.2. Neurological Disorders
  • 9.5.3. Gastrointestinal Disorders
  • 9.5.4. Diabetes
  • 9.5.5. Kidney Disorders
  • 9.5.6. Cardiovascular Disorders
  • 9.5.7. Others
• 9.6. Market Analysis, Insights and Forecast - By End-user
  • 9.6.1. Hospitals & ASCs
  • 9.6.2. Specialty Clinics
  • 9.6.3. Homecare Settings
  • 9.6.4. Others
• 9.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.7.1. Brazil
  • 9.7.2. Mexico
  • 9.7.3. Rest of Latin America

10. Middle East & Africa Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Service
    • 10.1.1.1. Nutrition Assessment
    • 10.1.1.2. Meal Preparation & Delivery
    • 10.1.1.3. Feeding Assistance
    • 10.1.1.4. Others
  • 10.1.2. Product
    • 10.1.2.1. Enteral Nutrition
    • 10.1.2.2. Parenteral Nutrition
      • 10.1.2.2.1. Partial Parenteral Nutrition (PPN)
      • 10.1.2.2.2. Total Parenteral Nutrition (TPN)
• 10.2. Market Analysis, Insights and Forecast - By Age Group
  • 10.2.1. Adults
  • 10.2.2. Pediatrics
• 10.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 10.3.1. Oral
  • 10.3.2. Nasal
  • 10.3.3. Parenteral
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By Form
  • 10.4.1. Powder
  • 10.4.2. Liquid
• 10.5. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 10.5.1. Oncology
  • 10.5.2. Neurological Disorders
  • 10.5.3. Gastrointestinal Disorders
  • 10.5.4. Diabetes
  • 10.5.5. Kidney Disorders
  • 10.5.6. Cardiovascular Disorders
  • 10.5.7. Others
• 10.6. Market Analysis, Insights and Forecast - By End-user
  • 10.6.1. Hospitals & ASCs
  • 10.6.2. Specialty Clinics
  • 10.6.3. Homecare Settings
  • 10.6.4. Others
• 10.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.7.1. GCC
  • 10.7.2. South Africa
  • 10.7.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2024)
• 11.2. Company Profiles
  • 11.2.1. Abbott
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & services
    • 11.2.1.3. Financials (Based on Availability)
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. SWOT,Etc.
  • 11.2.2. B. Braun SE
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & services
    • 11.2.2.3. Financials (Based on Availability)
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. SWOT,Etc.
  • 11.2.3. Nestle
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & services
    • 11.2.3.3. Financials (Based on Availability)
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. SWOT,Etc.
  • 11.2.4. Nutricia (Danone)
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & services
    • 11.2.4.3. Financials (Based on Availability)
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. SWOT,Etc.
  • 11.2.5. Baxter
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & services
    • 11.2.5.3. Financials (Based on Availability)
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. SWOT,Etc.
  • 11.2.6. Fresenius Kabi AG
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & services
    • 11.2.6.3. Financials (Based on Availability)
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. SWOT,Etc.
  • 11.2.7. Reckitt Benckiser Group PLC
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & services
    • 11.2.7.3. Financials (Based on Availability)
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. SWOT,Etc.
  • 11.2.8. Addus HomeCare, Inc.
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & services
    • 11.2.8.3. Financials (Based on Availability)
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. SWOT,Etc.
  • 11.2.9. Medtrition Inc.
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & services
    • 11.2.9.3. Financials (Based on Availability)
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. SWOT,Etc.
  • 11.2.10. Ajinomoto Co., Inc.
    • 11.2.10.1. Overview
    • 11.2.10.2. Products & services
    • 11.2.10.3. Financials (Based on Availability)
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. SWOT,Etc.